This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Albert Wionzek: Innovator in Pharmaceutical Active Agent Administration
Introduction
Albert Wionzek is a notable inventor based in Rüscheid, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the area of active agent administration systems. His innovative approach has led to the development of a unique method that enhances the delivery of pharmaceutical agents.
Latest Patents
Wionzek holds a patent for a "Method for producing active agent administering systems by means of pad printing processes." This invention relates to a pad printing method designed for creating an administration form for pharmaceutical active agents. The method involves providing a substrate for the administration form and transferring the active agent using a pad from a cliché onto the substrate. Notably, the area of the cliché is larger than the active-agent-containing area printed onto the substrate. This technique is particularly effective for producing transdermal therapeutic systems that utilize volatile active agents.
Career Highlights
Wionzek is associated with LTS Lohmann Therapie-Systeme AG, a company known for its advancements in therapeutic systems. His work has been instrumental in developing innovative solutions that improve the efficacy of drug delivery methods. With a focus on practical applications, Wionzek's contributions have the potential to enhance patient care and treatment outcomes.
Collaborations
Wionzek has collaborated with notable colleagues, including Thomas Hille and Petra Botzem. Their combined expertise has fostered an environment of innovation and creativity, leading to advancements in pharmaceutical technologies.
Conclusion
Albert Wionzek's contributions to the field of pharmaceutical active agent administration highlight his role as an innovator. His patented method showcases the potential for improved drug delivery systems, ultimately benefiting patients and healthcare providers alike.
